封面
市場調查報告書
商品編碼
2148305

全球及美國動物用藥品市場:依藥物類型、劑型、適應症、動物類型、給藥途徑、劑型、通路及地區分類

Global and U.S. Veterinary Drugs Market, By Drug Type, By Type, By Indication, By Animal Type, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 257 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球和美國動物用藥品動物用藥品預計到 2026 年將達到 249.58 億美元,預計到 2033 年將達到 481.975 億美元。從 2026 年到 2033 年,預計複合年成長率為 9.9%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 249.58億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 9.90% 2033年市場規模預測: 481.975億美元

全球及美國動物用藥品市場是一個重要的細分市場,其產品包括用於預防和治療伴侶動物、家畜和水生生物疾病的抗生素、驅蟲藥、抗發炎藥和鎮痛藥等。全球動物用藥品需求成長的促進因素包括寵物日益「人性化」、對動物源性蛋白質需求的不斷成長、通用感染疾病的蔓延以及人們對動物福利日益成長的關注。

在美國,由美國動物用藥品管理局獸藥中心( FDA-CVM)主導的健全監管體系確保了動物用藥品的安全、有效和品質。在全球範圍內,畜牧業生產的擴張、都市化進程的加快以及人們對動物健康意識的提高,正在創造新的成長機遇,而抗生素抗藥性問題則推動了藥物研發和合理使用方面的創新。

市場動態

全球和美國動物用藥品市場的發展主要受寵物數量成長、動物性蛋白質消費量增加以及對系統性動物用藥品保健需求上升的驅動。生物製藥、專科療法和創新藥物傳遞系統等獸藥領域的進步,正在創造新的治療選擇。此外,新興經濟體動物保健基礎設施的改善也擴大了動物用藥品的可近性。

然而,有機膠囊市場的成長受到許多因素的限制,例如嚴格的監管要求、日益嚴重的抗生素抗藥性問題以及高昂的獸醫費用。儘管如此,預防性動物保健的日益普及、數位化獸醫服務的發展、水產養殖健康管理的加強以及對無抗生素動物產品需求的成長,都為創新疫苗、長效療法以及基於精準醫療的獸醫學創造了巨大的發展機會。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數,對全球和美國動物用藥品市場的主要公司進行了概況介紹:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使行銷負責人和企業經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球和美國動物用藥品市場報告的目標受眾是該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球和美國動物用藥品市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 產業趨勢

第4章:全球及美國動物用藥品市場:依藥物類型分類,2021-2033年

  • 抗生素
  • 非類固醇消炎劑
  • 驅蟲
  • 抗組織胺藥
  • 止吐藥
  • 抗潰瘍藥物
  • 利尿劑
  • 麻醉劑
  • 抗癌藥物
  • 荷爾蒙製劑和荷爾蒙替代藥物
  • 其他

第5章:全球及美國動物用藥品市場:依類型分類,2021-2033年

  • 品牌
  • 學名藥

第6章:全球及美國動物用藥品市場:依適應症分類,2021-2033年

  • 消化器官系統疾病
  • 免疫系統疾病
  • 神經系統疾病
  • 生殖系統疾病
  • 呼吸系統疾病
  • 皮膚病
  • 腫瘤學
  • 內分泌疾病
  • 心血管疾病
  • 其他

第7章 全球及美國動物用藥品市場:依動物類型分類,2021-2033年

  • 伴侶動物
  • 家畜

第8章:全球及美國動物用藥品市場:依給藥途徑分類,2021-2033年

  • 口服
  • 腸外
  • 外用

第9章:全球及美國動物用藥品市場:依劑型分類,2021-2033年

  • 片劑和膠囊
  • 懸浮液和乳液
  • 粉末和糊狀物
  • 凝膠、乳霜、軟膏
  • 噴
  • 其他

第10章:全球及美國動物用藥品市場:依通路分類,2021-2033年

  • 動物醫院
  • 動物診所
  • 零售藥房
  • 網路藥房
  • 其他

第11章:全球及美國動物用藥品市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第12章 競爭格局

  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Virbac SA
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals Limited
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Norbrook Laboratories Limited

第13章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第14章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI10028

Global and U.S. Veterinary Drugs Market is estimated to be valued at USD 24,905.8 Mn in 2026 and is expected to reach USD 48,197.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 24,905.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.90% 2033 Value Projection: USD 48,197.5 Mn

The global and U.S. veterinary drugs market is a significant segment comprising pharmaceuticals such as antibiotics, antiparasitic, anti-inflammatories, and analgesics used to prevent and treat diseases in companion animals, livestock, and aquatic species. The demand for veterinary pharmaceuticals is being driven globally by the increasing pet humanization, growing demand for animal-derived protein, increasing prevalence of zoonotic diseases, and growing focus on animal welfare.

In the U.S., the safety, efficacy and quality of veterinary drugs is ensured by a robust regulatory system led by the U.S. FDA's Center for Veterinary Medicine (FDA-CVM). On the global scale, growing livestock production, urbanization and heightened awareness of animal health are creating new opportunities for growth, while antimicrobial resistance is spurring innovation in drug development and responsible use.

Market Dynamics

The global and U.S. veterinary drugs market is driven by the rising pet population, increasing animal protein consumption, and rising demand for systematic livestock healthcare. Advancements in veterinary pharmaceuticals such as biologics, specialized therapies, and innovative drug-delivery systems, are creating extra treatment options, and the improvement of veterinary healthcare infrastructure in emerging economies is widening access to animal medicines.

However, the growth of organic capsules market is limited by factors such as stringent regulatory requirements, increasing concerns related to antimicrobial resistance and high veterinary treatment costs. Nevertheless, the growing trend toward preventive animal healthcare, development of digital veterinary services, increasing aquaculture health management and demand for antibiotic-free animal products are creating significant opportunities for innovative vaccines, long-acting therapies and precision-based veterinary treatments.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global and U.S. veterinary drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Virbac S.A., Ceva Sante Animale S.A., Dechra Pharmaceuticals Limited, Vetoquinol S.A., Phibro Animal Health Corporation, and Norbrook Laboratories Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global and U.S. veterinary drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global and U.S. veterinary drugs market

Market Segmentation

  • Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Antibiotics
    • Nonsteroidal Anti-inflammatory Drug
    • Antiparasitic Drugs
    • Antihistamines
    • Antiemetic Drugs
    • Anti-ulcer Agents
    • Diuretics
    • Anaesthetic Agents
    • Anticancer Agents
    • Hormonal and Hormone Replacement Agents
    • Others
  • Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Branded
    • Generics
  • Indication Insights (Revenue, USD Mn, 2021 - 2033)
    • Digestive System Disease
    • Immunologic Disease
    • Nervous System Disease
    • Reproductive System Disease
    • Respiratory System Disease
    • Dermatological Disease
    • Oncology
    • Hormonal Disorder
    • Cardiovascular Disease
    • Others
  • Animal Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Companion Animal
    • Livestock
  • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
    • Oral
    • Parenteral
    • Topical
  • Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
    • Tablets and Capsules
    • Suspensions and Emulsions
    • Powders and Pastes
    • Gels, Creams and Ointments
    • Sprays
    • Others
  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
    • Veterinary Hospitals
    • Veterinary Clinics
    • Retail Pharmacies
    • Online Pharmacies
    • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Zoetis Inc.
    • Boehringer Ingelheim International GmbH
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Virbac S.A.
    • Ceva Sante Animale S.A.
    • Dechra Pharmaceuticals Limited
    • Vetoquinol S.A.
    • Phibro Animal Health Corporation
    • Norbrook Laboratories Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global and U.S. Veterinary Drugs Market, By Drug Type
    • Global and U.S. Veterinary Drugs Market, By Type
    • Global and U.S. Veterinary Drugs Market, By Indication
    • Global and U.S. Veterinary Drugs Market, By Animal Type
    • Global and U.S. Veterinary Drugs Market, By Route of Administration
    • Global and U.S. Veterinary Drugs Market, By Dosage Form
    • Global and U.S. Veterinary Drugs Market, By Distribution Channel
    • Global and U.S. Veterinary Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global and U.S. Veterinary Drugs Market, By Drug Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Nonsteroidal Anti-inflammatory Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Antiparasitic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Antihistamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Antiemetic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Anti-ulcer Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diuretics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Anaesthetic Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Anticancer Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hormonal and Hormone Replacement Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global and U.S. Veterinary Drugs Market, By Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Generics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global and U.S. Veterinary Drugs Market, By Indication, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Digestive System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Immunologic Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Nervous System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Reproductive System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Respiratory System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Dermatological Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hormonal Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Cardiovascular Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global and U.S. Veterinary Drugs Market, By Animal Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Companion Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Livestock
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global and U.S. Veterinary Drugs Market, By Route of Administration, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global and U.S. Veterinary Drugs Market, By Dosage Form, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Tablets and Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Suspensions and Emulsions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Powders and Pastes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Gels, Creams and Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global and U.S. Veterinary Drugs Market, By Distribution Channel, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

11. Global and U.S. Veterinary Drugs Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

12. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva Sante Animale S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Norbrook Laboratories Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

13. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

14. References and Research Methodology

  • References
  • Research Methodology
  • About us